HEALWELL AI Reports Record Q3 Revenue and Strategic Growth

HEALWELL AI ( (TSE:AIDX) ) just unveiled an update.

HEALWELL AI Inc. reported a significant increase in revenue for Q3 2025, driven by the acquisition of Orion Health and strategic divestments that sharpen its focus on AI and SaaS healthcare solutions. The company achieved a 354% year-over-year revenue growth and marked its second consecutive quarter of positive Adjusted EBITDA, highlighting improved financial performance and execution of its growth strategy. HEALWELL’s full ownership of Pentavere Research Group and strategic collaborations in the Middle East are set to enhance its AI segment, positioning it as a leading player in the global healthcare market.

The most recent analyst rating on (TSE:AIDX) stock is a Buy with a C$5.00 price target. To see the full list of analyst forecasts on HEALWELL AI stock, see the TSE:AIDX Stock Forecast page.

Spark’s Take on TSE:AIDX Stock

According to Spark, TipRanks’ AI Analyst, TSE:AIDX is a Neutral.

HEALWELL AI’s overall stock score is primarily influenced by its strong revenue growth, despite significant profitability and cash flow challenges. Technical analysis shows mild bullish momentum, but valuation remains unattractive due to ongoing losses. The absence of earnings call data and corporate events limits additional insights.

To see Spark’s full report on TSE:AIDX stock, click here.

More about HEALWELL AI

HEALWELL AI Inc. is a healthcare artificial intelligence company focused on preventative care, offering global SaaS, services, and AI solutions for health systems and life sciences. The company is dedicated to developing advanced AI-powered healthcare technologies and has a market focus on preventative care solutions.

Average Trading Volume: 428,511

Technical Sentiment Signal: Sell

Current Market Cap: C$428.3M

See more data about AIDX stock on TipRanks’ Stock Analysis page.